Illumina, Inc. (NASDAQ ... delivering the NovaSeq X single-flow-cell system alongside a cutting-edge software upgrade and new kits.

The US Single-Cell Analysis Market is projected to reach US$2,695.3 million by 2029 from an estimated US$1,378.6 million in 2024, at a CAGR ...

It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation ...

It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation ...

Gut microbiota composition and sex hormones influence the immune response to methicillin-resistant Staphylococcus aureus gastrointestinal colonization in mice.

Illumina ranks as the largest player in genetic ... test panels, reagents, and flow cells. Services often contribute 10% or more to revenue and help increase customer value by improving sequencing ...

Sample libraries were balanced for the number of estimated reads per cell and run on an Illumina NovaSeq system on a NovaSeq S1 flow cell at the University of Wisconsin–Madison Biotechnology Center ...